Clinical Trial: Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414212) titled 'Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)' on Feb. 02.

Brief Summary: This study is designed to evaluate whether a combination of N-acetylcysteine (NAC) and EH-301 can slow down or improve symptoms of amyotrophic lateral sclerosis (ALS). Researchers will assess changes in disease progression using the ALS Functional Rating Scale-Revised (ALSFRS-R), a standard tool for measuring daily functioning in people with ALS.

The main question is whether taking NAC together with EH-301 can prevent symptom worsening and possibly improve existing ALS symptoms....